Multiple crossover designs with an antianxiety agent and an antidepressant
- PMID: 493459
Multiple crossover designs with an antianxiety agent and an antidepressant
Similar articles
-
Diazepam in psychiatry.Ther Hung. 1967;15(3):109-11. Ther Hung. 1967. PMID: 4866483 Clinical Trial. No abstract available.
-
[Double-blind cross-over clinical study of a new psychopharmaceutic agent: thiadipone (QM-6008), diazepam and a placebo].Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1980 Nov-Dec;8(6):409-42. Actas Luso Esp Neurol Psiquiatr Cienc Afines. 1980. PMID: 7008536 Clinical Trial. Spanish. No abstract available.
-
Chlorpromazine-chlordiazepoxide and chlorpromazine-imipramine treatment of newly hospitalized, acutely ill psychiatric patients.Curr Ther Res Clin Exp. 1966 Mar;8(3):Suppl:117-52. Curr Ther Res Clin Exp. 1966. PMID: 4956162 Clinical Trial. No abstract available.
-
Methods and models for placebo use in pharmacotherapeutic trials.Psychopharmacol Bull. 1988;24(1):4-8. Psychopharmacol Bull. 1988. PMID: 3290947 Review. No abstract available.
-
Studies on the effectiveness of antidepressant drugs.Psychopharmacol Bull. 1969 Mar:Suppl:1-53. Psychopharmacol Bull. 1969. PMID: 4898337 Review. No abstract available.
Cited by
-
Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over design.Psychopharmacology (Berl). 1985;87(2):130-5. doi: 10.1007/BF00431795. Psychopharmacology (Berl). 1985. PMID: 3931136 Clinical Trial.